| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA2060580 | F | Agonist activity at human CB2 receptor expressed in CHO cells assessed as [35S]-GTPgammaS binding preincubated for 25 mins measured after 30 mins by scintillation proximity assay | Homo sapiens | 12 | cell-based format | Scientific Literature | ||
| 2. | ALA2060581 | F | Agonist activity at human CB2 receptor expressed in CHO cells assessed as [35S]-GTPgammaS binding preincubated for 25 mins measured after 30 mins by scintillation proximity assay relative to control | Homo sapiens | 12 | cell-based format | Scientific Literature | ||
| 3. | ALA2060583 | F | Agonist activity at human CB1 receptor expressed in CHO cells assessed as [35S]-GTPgammaS binding preincubated for 25 mins measured after 30 mins by scintillation proximity assay | Homo sapiens | 12 | cell-based format | Scientific Literature | ||
| 4. | ALA2060586 | A | Induction of hypothermia in monoiodoacetic acid rat model of osteoarthritic pain up to 30 mg/kg, po | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 5. | ALA2060588 | F | Analgesic activity in po dosed monoiodoacetic acid rat model of osteoarthritic pain assessed as decrease in pain measured after 29 days relative to control | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 6. | ALA2060589 | A | Oral bioavailability in beagle dog at 3 mg/kg | Canis lupus familiaris | 1 | organism-based format | Scientific Literature | ||
| 7. | ALA2060590 | A | Cmax in beagle dog at 1 mg/kg, iv and 3 mg/kg, po | Canis lupus familiaris | 1 | organism-based format | Scientific Literature | ||
| 8. | ALA2060591 | A | AUC in beagle dog at 1 mg/kg, iv and 3 mg/kg, po | Canis lupus familiaris | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA2060592 | A | Half life in beagle dog at 3 mg/kg, po | Canis lupus familiaris | 1 | organism-based format | Scientific Literature | ||
| 10. | ALA2060593 | A | Volume of distribution in beagle dog at 1 mg/kg, iv | Canis lupus familiaris | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA2060594 | A | Clearance in beagle dog at 1 mg/kg, iv | Canis lupus familiaris | 1 | organism-based format | Scientific Literature | ||
| 12. | ALA2060595 | A | Efflux ratio of permeability across MDCK cells expressing MDR1 at 5 uM in presence of P-glycoprotein inhibitor | Canis lupus familiaris | 1 | cell-based format | Scientific Literature | ||
| 13. | ALA2060596 | A | Permeability across basolateral to apical side in MDCK cells expressing MDR1 at 5 uM in presence of P-glycoprotein inhibitor | Canis lupus familiaris | 1 | cell-based format | Scientific Literature | ||
| 14. | ALA2060597 | A | Permeability across apical to basolateral side in MDCK cells expressing MDR1 at 5 uM in presence of P-glycoprotein inhibitor | Canis lupus familiaris | 1 | cell-based format | Scientific Literature | ||
| 15. | ALA2060598 | A | Efflux ratio of permeability across MDCK cells expressing MDR1 at 5 uM | Canis lupus familiaris | 1 | cell-based format | Scientific Literature | ||
| 16. | ALA2060599 | A | Permeability across basolateral to apical side in MDCK cells expressing MDR1 at 5 uM | Canis lupus familiaris | 1 | cell-based format | Scientific Literature | ||
| 17. | ALA2060600 | A | Permeability across apical to basolateral side in MDCK cells expressing MDR1 at 5 uM | Canis lupus familiaris | 1 | cell-based format | Scientific Literature | ||
| 18. | ALA2060601 | A | Cmax in Sprague-Dawley rat at 1 mg/kg, iv and 1 mg/kg, po | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 19. | ALA2060602 | A | AUC in Sprague-Dawley rat at 1 mg/kg, iv and 1 mg/kg, po | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 20. | ALA2060603 | A | Half life in Sprague-Dawley rat at 1 mg/kg, po | Rattus norvegicus | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!